Immunic, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $-9.2M | $-9.5M | $261.0K | $144.0K |
| FY2013 | $-28.6M | $-30.1M | $1.5M | $948.0K |
| FY2014 | $-40.8M | $-42.2M | $1.4M | $2.5M |
| FY2015 | $-50.0M | $-52.3M | $2.3M | $4.0M |
| FY2016 | $-35.8M | $-36.3M | $556.0K | $4.7M |
| FY2017 | $-40.4M | $-41.1M | $685.0K | $5.5M |
| FY2018 | $-9.7M | $-9.8M | $32.0K | $0 |
| FY2019 | $-28.5M | $-28.6M | $55.0K | $6.5M |
| FY2020 | $-46.1M | $-46.3M | $146.0K | $2.7M |
| FY2021 | $-83.2M | $-83.3M | $67.0K | $5.9M |
| FY2022 | $-65.1M | $-65.3M | $112.0K | $7.9M |
| FY2023 | $-70.8M | $-71.2M | $334.0K | $7.1M |
| FY2024 | $-84.8M | $-85.0M | $264.0K | $8.5M |
| FY2025 | $-85.8M | $-86.0M | $161.0K | $8.9M |